InvestorsHub Logo
Followers 7
Posts 586
Boards Moderated 0
Alias Born 08/25/2012

Re: roadkilll post# 129

Tuesday, 12/07/2021 9:27:52 PM

Tuesday, December 07, 2021 9:27:52 PM

Post# of 163
Piper Sandler presentation
60mg dose not in phase 3 showed 19% NASH Resolution
80 mg dose in phase 2 trial = 38% resolution
Better is that the phase 3 trial has a 100mg arm and with the safety data coming in it looks like the ideal dose for an even higher resolution percentage.

Also, the company has been in talks with multiple Big Pharma about partnering. Madrigal feel confident enough that they feel no partnering will take place until after the final phase 3 data is presented in 2022.

Glad this one is off the radar and may give me another chance to add shares at lower prices.
Day Range:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MDGL News